ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Carboplatin is on this study

  • The record lists it as a treatment.
  • A model not recorded judged it given beside what the study tests. Nov 1, 2026, 6:35 AM UTC
  • The role rule says the same.
  • So Carboplatin's page lists this study under “Given beside what is tested”.
7 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)0 record changes seen
Model not recordedRule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05929768Shorter Chemo-ImmunotherapyWithout Anthracycline Drugsfor Early-Stage TripleNegative Breast CancerSWOG Cancer Research NetworkPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSCarboplatinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorDocetaxelIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedDoxorubicinIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorPaclitaxelIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · ComparatorComparatorPembrolizumabIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1CarboplatinA model not recordedBackgroundCurrent
Nov 1CyclophosphamideA model not recordedComparatorCurrent
Nov 1DocetaxelA model not recordedTestedCurrent
Nov 1DoxorubicinA model not recordedComparatorCurrent
Nov 1PaclitaxelA model not recordedComparatorCurrent
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 18CarboplatinRule based · role ruleBackgroundAgrees
Nov 18CyclophosphamideRule based · role ruleComparatorAgrees
Nov 18DocetaxelRule based · role ruleTestedAgrees
Nov 18DoxorubicinRule based · role ruleComparatorAgrees
Nov 18PaclitaxelRule based · role ruleComparatorAgrees
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.